CN106173751A - 一种治疗尿毒症的保健饮品及其制备方法 - Google Patents
一种治疗尿毒症的保健饮品及其制备方法 Download PDFInfo
- Publication number
- CN106173751A CN106173751A CN201610634089.6A CN201610634089A CN106173751A CN 106173751 A CN106173751 A CN 106173751A CN 201610634089 A CN201610634089 A CN 201610634089A CN 106173751 A CN106173751 A CN 106173751A
- Authority
- CN
- China
- Prior art keywords
- parts
- health promoting
- promoting beverage
- beverage
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 41
- 230000001737 promoting effect Effects 0.000 title claims abstract description 41
- 235000013361 beverage Nutrition 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims description 8
- 239000002994 raw material Substances 0.000 claims abstract description 25
- 244000236655 Diospyros kaki Species 0.000 claims abstract description 19
- 235000008597 Diospyros kaki Nutrition 0.000 claims abstract description 19
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 14
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 14
- 239000006041 probiotic Substances 0.000 claims abstract description 4
- 235000018291 probiotics Nutrition 0.000 claims abstract description 4
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 16
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 238000007789 sealing Methods 0.000 claims description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000009924 canning Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000009849 vacuum degassing Methods 0.000 claims description 5
- 235000021551 crystal sugar Nutrition 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical group O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 239000003814 drug Substances 0.000 abstract description 8
- 208000004880 Polyuria Diseases 0.000 abstract description 7
- 230000035619 diuresis Effects 0.000 abstract description 7
- 230000033228 biological regulation Effects 0.000 abstract description 5
- 206010010774 Constipation Diseases 0.000 abstract description 4
- 230000036772 blood pressure Effects 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 3
- 230000003907 kidney function Effects 0.000 abstract description 2
- 230000000050 nutritive effect Effects 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 description 9
- 208000037157 Azotemia Diseases 0.000 description 8
- 208000009852 uremia Diseases 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 239000000686 essence Substances 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229940126701 oral medication Drugs 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 208000001889 Acid-Base Imbalance Diseases 0.000 description 1
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010006100 Bradykinesia Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 208000037487 Endotoxemia Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000209051 Saccharum Species 0.000 description 1
- 208000003837 Second Primary Neoplasms Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 229910052683 pyrite Inorganic materials 0.000 description 1
- 239000011028 pyrite Substances 0.000 description 1
- -1 pyrite glycoside Chemical class 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/44—Ebenaceae (Ebony family), e.g. persimmon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种治疗尿毒症的保健饮品，所述保健饮品包括以下重量份的原料：柿叶60‑100份，山药20‑50份，鸡脚参5‑10份，枸杞10‑20份，大枣10‑20份，三七5‑10份，茯苓1‑5份，车前子1‑10份。本发明公开的保健饮品，采用天然药物与有益菌有效结合，更加有效的利用了更组分的有益成分，起到了事半功倍的作用。本发明提供的保健饮品口感好，营养价值高，方便饮用，具有提高机体免疫力、调节血压、利尿通便、改善肾功能、增强体质，并对治疗尿毒症患者有显著的疗效。
Description
技术领域
本发明涉及保健饮品技术领域，具体涉及一种治疗尿毒症的保健饮品及其制备方法。
背景技术
尿毒症是指急性或慢性肾功能不全发展到严重阶段时，由于代谢物蓄积和水、电解质和酸碱平衡紊乱以致内分泌功能失调而引起机体出现的一系列自体中毒症状称之为尿毒症。尿毒症隐蔽性极高，素有“隐形杀手”的称号。且发率极高，又有“第二癌症”之称。症状包括纳差、恶心呕吐、头痛、乏力和夜尿多等，多数病人口中有异味、口腔粘膜溃疡、鼻出血或消化道出血，还会出现注意力不集中、反应迟钝、肢体麻木、嗜睡或躁动不安等神经精神症状。目前，治疗尿毒症最为常见的莫过于西医所创的肾透析和肾移植：于透析而言，是一种能快速消除体内毒素的最直接办法，但患者除必须承受巨额的经济负担之外，对人体本身也是一种伤害且有严格的适应症和禁忌；于换肾而言，肾源少、配型难、成功率小、排斥现象一时难以解决，再加上费用昂贵，往往使患者苦不堪言甚至望而却步。相对的，中医则在一定程度上克服了其中的一些问题，比如灌肠法，有一定的结肠透析作用，是清除体内氮质的一个重要途径，为口服药物的补充，尤其对不能口服药物的病人更为适宜。
中医讲究药食同源，其实说中药与食物是同时起源的，前人已经证明了它们的保健作用和安全性，日常生活中，许多饮品是人类巧妙地利用有益微生物加工制造的一类产品，通过发酵使饮品中原有的营养成分发生改变并产生独特的风味-简单的说，加入的微生物就像一台台小小的加工机，对饮品的每个细胞进行处理，增加一些有益成分，去除一些无益的成分，顺便改变味道和质地，发酵时微生物分泌的酶能裂解细胞壁，提高营养素的利用程度，在发酵的过程中，微生物保留了原来原料的一些活性成分，如多糖、膳食纤维、生物类黄酮等对机体有益的物质，还能分解某些对人体比例的因子，如豆类中的胀气因子等。微生物新陈代谢是产生不少代谢产物，多数有调节机体生物功能的作用，能抑制体内有害物的产生。
在众多保健饮品中，还没有报道过对尿毒症有治疗作用的保健饮品。
发明内容
为了开发一款兼具保健和治疗作用的保健饮品，发明人作了大量调查和实验，发现了一种兼具保健和对慢性尿毒症起作用的保健饮品。
为实现上述目的，本发明首先提供一种治疗尿毒症的保健饮品，所述保健饮品包括以下重量份的原料：柿叶60-100份，山药20-50份，鸡脚参5-10份，枸杞10-20份，大枣10-20份，三七5-10份，茯苓1-5份，车前子1-10份。
优选的，所述保健饮品包括以下重量份的原料：柿叶80份，山药40份，鸡脚参7份，枸杞10份，大枣12份，三七6份，茯苓2份，车前子6份。
本发明所选原料柿叶，味苦、性寒、无毒，入肺经，柿叶入药已有悠久历史，其功效在《本草在新》、《本草衍生》、《中草药学》、《中药大辞典》等医学典籍中均有记载。中医认为：柿叶可以清脑明目、消炎解热、降低血压、增加心脏冠状动脉血流量、防止人体内亚硝酸胺的合成等功效，经常饮用能增进机体组织新陈代谢。它含有芦丁、胆碱、蛋白质、矿物质、糖等，突出的是每100克干柿叶中维生素c含量达3500毫克左右。国家级名老中医陈老明确指出：柿叶有利小便、通大便，在清血、软化血管、降血压方面有明显效果。已是我国国家级名老中医的经验用药，许多资料搜集也证明了这一点。此外，现代研究还证实柿叶中含有柿叶黄铜甙、熊果酸等对尿毒症有益的组分。山药，性味甘、平，归脾、肺、肾经，补脾养胃，生津益肺，补肾涩精。用于脾虚食少，久泻不止，肺虚喘咳，肾虚遗精，带下，尿频，虚热消渴。鸡脚参，辛、甘，平；祛风利尿，镇痛化积，接骨生肌。用于食积，脉管炎，肾炎，膀胱炎，尿路结石，风湿痛；外用治跌打损伤，骨折。枸杞，性味甘、平，归肝、肾经，滋补肝肾，益精明目。用于虚劳精亏，腰膝酸痛，眩晕耳鸣，内热消渴，血虚萎黄，目昏不明。三七，甘、微苦，温，归肝、胃经，散瘀止血，消肿定痛；用于咯血，吐血，衄血，便血，崩漏，外伤出血，胸腹剌痛，跌扑肿痛。配方中的大枣能够补脾和胃，益气生津，调营卫，解药毒的作用；茯苓，甘、淡，平，归心、肺、脾、肾经，利水渗湿，健脾宁心。用于水肿尿少，痰饮眩悸，脾虚食少，便溏泄泻，心神不安，惊悸失眠；车前子，甘、微寒，归肝、肾、肺、小肠经。清热利尿，渗湿通淋，明目，祛痰。用于水肿胀满，热淋涩痛，暑湿泄泻，目赤肿痛，痰热咳嗽。
进一步地，所述保健饮品还包括双歧杆菌0.1-1份。优选的，双歧杆菌为0.3份。每克所述双歧杆菌含有活菌数为15-17亿。
本发明选用了最佳的天然活性菌双歧杆菌，近年来发现双歧杆菌具有以下治疗效果：维护肠道正常细菌菌群平衡，抑制病原菌的生长，防止便秘，下痢和胃肠障碍等；抗肿瘤；在肠道内合成维生素、氨基酸和提高机体对钙离子的吸收；降低血液中胆固醇水平，防治高血压；改善乳制品的耐乳糖性，提高消化率；增强人体免疫机能，预防抗生素的副作用，抗衰老，延年益寿；增强机体的非特异和特异性免疫反应；控制内毒素血症的作用；提高宿主对放射线的耐受性。双歧杆菌在母乳喂养儿肠道内大量存在，对婴幼儿有许多好处，如营养、免疫及抗感染作用。并且还具有抗过敏、抗肿瘤、调整肠道功能及改善营养的作用等。在临床上，双歧杆菌具有调整肠道功能紊乱作用。可以预防腹泻，减少便秘，即双向调节。这种调节能起到预防和治疗各种肠道疾病的效果。本发明选用的双歧杆菌与天然药物有机结合，起到了意想不到的效果，在治疗尿毒症方面具有显著的作用。
进一步地，本发明所述保健饮品还包括甜味剂20-50份。优选的，所述甜味剂为白砂糖或冰糖。所述甜味剂在所述保健饮品中占的份数为0.3份。
更进一步地，本发明还提供了一种治疗尿毒症的保健饮品的制备方法，其包括以下步骤：
(1)按比例称取柿叶、山药、手参、枸杞、大枣、三七、茯苓和车前子原料，并洗净、烘干、粉碎；
(2)将步骤(1)准备好的各原料混合均匀后放入密闭容器中，加入原材料重量份1000-1200倍的纯净水，同时加入甜味剂和双歧杆菌，密封搁置，并将密闭容器搁置在18-23℃环境内，搁置20-30天；
(3)在无菌条件下，过滤，取滤液真空脱气、均质，罐装密封。
有益效果
本发明公开的保健饮品，采用天然药物与有益菌有效结合，更加有效的利用了更组分的有益成分，起到了事半功倍的作用。本发明提供的保健饮品口感好，营养价值高，方便饮用，具有提高机体免疫力、调节血压、利尿通便、改善肾功能、增强体质，并对治疗尿毒症患者有显著的疗效。
具体实施方式
以下实施例用于说明本发明，但不用来限制本发明的范围。若未特别指明，实施例中所用的技术手段为本领域技术人员所熟知的常规手段。
实施例1
各原料重量份如下：柿叶95份，山药20份，鸡脚参6份，枸杞12份，大枣12份，三七5份，茯苓4份，车前子2份。
制备方法如下：
(1)按比例称取柿叶、山药、手参、枸杞、大枣、三七、茯苓和车前子原料，并洗净、烘干、粉碎；
(2)将步骤(1)准备好的各原料混合均匀后放入密闭容器中，加入原材料重量份1000倍的纯净水，同时加入甜味剂30份和双歧杆菌0.2份，密封搁置，并将密闭容器搁置在18-23℃环境内，搁置20天；
(3)在无菌条件下，过滤，取滤液真空脱气、均质，罐装密封。
实施例2
各原料重量份如下：柿叶80份，山药50份，鸡脚参10份，枸杞15份，大枣10份，三七8份，茯苓3份，车前子5份。
制备方法如下：
(1)按比例称取柿叶、山药、手参、枸杞、大枣、三七、茯苓和车前子原料，并洗净、烘干、粉碎；
(2)将步骤(1)准备好的各原料混合均匀后放入密闭容器中，加入原材料重量份1000倍的纯净水，同时加入甜味剂20份和双歧杆菌0.9份，密封搁置，并将密闭容器搁置在18-23℃环境内，搁置30天；
(3)在无菌条件下，过滤，取滤液真空脱气、均质，罐装密封。
实施例3
各原料重量份如下：柿叶70份，山药40份，鸡脚参7份，枸杞10份，大枣12份，三七6份，茯苓5份，车前子9份。
制备方法如下：
(1)按比例称取柿叶、山药、手参、枸杞、大枣、三七、茯苓和车前子原料，并洗净、烘干、粉碎；
(2)将步骤(1)准备好的各原料混合均匀后放入密闭容器中，加入原材料重量份1000倍的纯净水，同时加入甜味剂30份和双歧杆菌0.3份，密封搁置，并将密闭容器搁置在18-23℃环境内，搁置25天；
(3)在无菌条件下，过滤，取滤液真空脱气、均质，罐装密封。
临床应用例1
赵某，女，56岁，四肢乏力、出现血尿、尿痛并出现浮肿的等症状，经确诊为：慢性肾炎晚期尿毒症，服用本发明的保健饮料3个月以后，临床症状明显缓解。
虽然，上文中已经用一般性说明及具体实施方案对本发明作了详尽的描述，但在本发明基础上，可以对之作一些修改或改进，这对本领域技术人员而言是显而易见的。因此，在不偏离本发明精神的基础上所做的这些修改或改进，均属于本发明要求保护的范围。
Claims (10)
1.一种治疗尿毒症的保健饮品，其特征在于，所述保健饮品包括以下重量份的原料：柿叶60-100份，山药20-50份，鸡脚参5-10份，枸杞10-20份，大枣10-20份，三七5-10份，茯苓1-5份，车前子1-10份。
2.如权利要求1所述的保健饮品，其特征在于，所述保健饮品包括以下重量份的原料：柿叶80份，山药40份，鸡脚参7份，枸杞10份，大枣12份，三七6份，茯苓2份，车前子6份。
3.如权利要求1或2所述的保健饮品，其特征在于，所述保健饮品还包括有益菌0.1-1份。
4.如权利要求3所述的保健饮品，其特征在于，所述有益菌为双歧杆菌。
5.如权利要求4所述的保健饮品，其特征在于，每克所述双歧杆菌含有活菌数为8-12亿。
6.如权利要求4所述的保健饮品，其特征在于，所述双歧杆菌在所述保健饮品中占的份数为0.3份。
7.如权利要求3所述的保健饮品，其特征在于，所述保健饮品还包括甜味剂20-50份。
8.如权利要求7所述的保健饮品，其特征在于，所述甜味剂为白砂糖或冰糖。
9.如权利要求7所述的保健饮品，其特征在于，所述甜味剂在所述保健饮品中占的份数为0.3份。
10.一种治疗尿毒症的保健饮品的制备方法，其包括以下步骤：
(1)按比例称取柿叶、山药、鸡脚参、枸杞、大枣、三七、茯苓和车前子原料，并洗净、烘干、粉碎；
(2)将步骤(1)准备好的各原料混合均匀后放入密闭容器中，加入原材料重量份1000-1200倍的纯净水，同时加入甜味剂和双歧杆菌，密封搁置，并将密闭容器搁置在18-23℃环境内，搁置20-30天；
(3)在无菌条件下，过滤，取滤液真空脱气、均质，罐装密封。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610634089.6A CN106173751A (zh) | 2016-08-05 | 2016-08-05 | 一种治疗尿毒症的保健饮品及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610634089.6A CN106173751A (zh) | 2016-08-05 | 2016-08-05 | 一种治疗尿毒症的保健饮品及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106173751A true CN106173751A (zh) | 2016-12-07 |
Family
ID=57498116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610634089.6A Pending CN106173751A (zh) | 2016-08-05 | 2016-08-05 | 一种治疗尿毒症的保健饮品及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106173751A (zh) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1232689A (zh) * | 1998-12-28 | 1999-10-27 | 赵耀宗 | 一种治疗肾病的药物 |
| CN1509144A (zh) * | 2001-05-15 | 2004-06-30 | \ | 益生素和益生菌组合物及其在肠道疾病治疗中的用法 |
| CN101693074A (zh) * | 2009-10-01 | 2010-04-14 | 冯子政 | 治疗肾病的药物 |
| CN104921238A (zh) * | 2015-05-22 | 2015-09-23 | 北京联华大通教育科技有限公司 | 一种排毒养颜的保健饮品及其制备方法 |
| CN106138166A (zh) * | 2016-07-26 | 2016-11-23 | 北京致成生物医学科技有限公司 | 一种柿叶药饮在治疗尿毒症中的应用 |
-
2016
- 2016-08-05 CN CN201610634089.6A patent/CN106173751A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1232689A (zh) * | 1998-12-28 | 1999-10-27 | 赵耀宗 | 一种治疗肾病的药物 |
| CN1509144A (zh) * | 2001-05-15 | 2004-06-30 | \ | 益生素和益生菌组合物及其在肠道疾病治疗中的用法 |
| CN101693074A (zh) * | 2009-10-01 | 2010-04-14 | 冯子政 | 治疗肾病的药物 |
| CN104921238A (zh) * | 2015-05-22 | 2015-09-23 | 北京联华大通教育科技有限公司 | 一种排毒养颜的保健饮品及其制备方法 |
| CN106138166A (zh) * | 2016-07-26 | 2016-11-23 | 北京致成生物医学科技有限公司 | 一种柿叶药饮在治疗尿毒症中的应用 |
Non-Patent Citations (2)
| Title |
|---|
| 张晓梅等: "《肾炎尿毒症调养与护理》", 31 May 1999, 中国中医药出版社 * |
| 贺志光: "《中医学 第3版》", 30 November 1983, 人民卫生出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103110861B (zh) | 一种预防婴幼儿上火调节肠胃的颗粒剂及其制备方法 | |
| CN102048933A (zh) | 一种治疗小儿腹泻的中药组合物及其制备方法 | |
| CN104643250A (zh) | 一种可双向调节体重改善亚健康的固体饮料 | |
| CN111387381A (zh) | 蓝靛果复合果汁饮料及其制备方法 | |
| CN105124605A (zh) | 一种保健咀嚼片及其制备方法 | |
| CN106387900A (zh) | 一种调节血脂、血压及血糖的组合物及其应用 | |
| CN103005264B (zh) | 一种含有壳寡糖的保健食品及其制备方法 | |
| CN113974162B (zh) | 一种汉方梨膏燕窝及一种汉方梨膏燕窝制备方法 | |
| CN106234896A (zh) | 一种治疗肾病的保健饮品及其制备方法 | |
| CN104783174A (zh) | 一种纯天然营养免疫保健固体饮料的配制方法 | |
| CN114191515A (zh) | 一种祛湿健胃、提高免疫能力口服凝胶及其制备方法 | |
| CN106562147A (zh) | 一种健脾祛湿、促进肠胃蠕动的植物混合饮料及其生产工艺 | |
| CN115399476A (zh) | 一种具有辅助润肠通便功能的食品组合物 | |
| CN106035811A (zh) | 一种排毒健体饮料 | |
| CN105876557A (zh) | 一种葛根护肝饮料及其制作方法 | |
| CN106234699A (zh) | 一种清热宣化治疗发热的药茶及制备加工方法 | |
| CN101744945A (zh) | 胃肠功能调节口服液 | |
| CN106173751A (zh) | 一种治疗尿毒症的保健饮品及其制备方法 | |
| CN106387571A (zh) | 一种含柿叶柿果的保健饮品及其制备方法 | |
| CN109875044A (zh) | 复合增免疫营养食品配方及其制备方法 | |
| CN110574848A (zh) | 一种氨基酸中药饮料及其制作方法 | |
| CN108685101A (zh) | 林蛙肽菊粉 | |
| CN107582829A (zh) | 一种防癌抗癌的功能食品 | |
| CN101721523A (zh) | 一种治疗胃病的药物 | |
| CN106107259A (zh) | 一种葛根美容养颜饮料及其制作方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161207 |
|
| RJ01 | Rejection of invention patent application after publication |